Drug resistance profile of Mycobacterium tuberculosis isolates from patients referred to tuberculosis reference laboratory in Kosovo Bajrami R, Mulliqi G, Kurti A, Lila G, Raka L - Int J Mycobacteriol
The risk of drug resistance during long-acting antimicrobial therapy | medRxiv
Clinical consequences of primary CMV infection after renal transplantation: a case–control study - Singh - 2020 - Transplant International - Wiley Online Library
![PDF] Mapping Factors that Drive Drug Resistance (with a Focus on Resource-Limited Settings): A First Step Towards Better Informed Policy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/068859872ad8d4e2dde00d9d5d4b94bc802f9e5e/13-Figure2-1.png "PDF] Mapping Factors that Drive Drug Resistance (with a Focus on Resource-Limited Settings): A First Step Towards Better Informed Policy | Semantic Scholar")
PDF] Mapping Factors that Drive Drug Resistance (with a Focus on Resource-Limited Settings): A First Step Towards Better Informed Policy | Semantic Scholar
Cells | Free Full-Text | CD8 and CD4 T Cell Populations in Human Kidneys
The risk of drug resistance during long-acting antimicrobial therapy | medRxiv
Cells | Free Full-Text | CD8 and CD4 T Cell Populations in Human Kidneys
Thomas FINDLEY | Professor (Full) | MD, PhD | Rutgers New Jersey Medical School, New Jersey | UMDNJ | Department of Physical Medicine and Rehabilitation | Research profile
Thesis Linn Dobrowolski_V26.indd
Cells | Free Full-Text | CD8 and CD4 T Cell Populations in Human Kidneys
The risk of drug resistance during long-acting antimicrobial therapy | medRxiv
Clinical consequences of primary CMV infection after renal transplantation: a case–control study - Singh - 2020 - Transplant International - Wiley Online Library
The risk of drug resistance during long-acting antimicrobial therapy | medRxiv
Clinical consequences of primary CMV infection after renal transplantation: a case–control study - Singh - 2020 - Transplant International - Wiley Online Library
Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib - ScienceDirect
PDF) Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia
Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib - ScienceDirect
Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib - ScienceDirect
The risk of drug resistance during long-acting antimicrobial therapy | medRxiv
![PDF] Mapping Factors that Drive Drug Resistance (with a Focus on Resource-Limited Settings): A First Step Towards Better Informed Policy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/068859872ad8d4e2dde00d9d5d4b94bc802f9e5e/31-Table12-1.png "PDF] Mapping Factors that Drive Drug Resistance (with a Focus on Resource-Limited Settings): A First Step Towards Better Informed Policy | Semantic Scholar")
PDF] Mapping Factors that Drive Drug Resistance (with a Focus on Resource-Limited Settings): A First Step Towards Better Informed Policy | Semantic Scholar
Thesis Linn Dobrowolski_V26.indd
Cells | Free Full-Text | CD8 and CD4 T Cell Populations in Human Kidneys
PDF) Clinical consequences of primary CMV infection after renal transplantation: a case‐control study
A polymeric approach toward resistance-resistant antimicrobial agent with dual-selective mechanisms of action | Science Advances
PDF) Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia
Deciphering drug resistance in Mycobacterium tuberculosis using whole-genome sequencing: progress, promise, and challenges | Genome Medicine | Full Text
